Shree Ganesh Bio-Tech (India) Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 179.6 million. Revenue was INR 179.62 million. Net income was INR 8.24 million compared to net loss of INR 0.353 million a year ago. Basic earnings per share from continuing operations was INR 0.0205 compared to basic loss per share from continuing operations of INR 0.001 a year ago. Diluted earnings per share from continuing operations was INR 0.0205 compared to diluted loss per share from continuing operations of INR 0.001 a year ago.
For the six months, sales was INR 334.76 million compared to INR 1.14 million a year ago. Revenue was INR 335.24 million compared to INR 1.14 million a year ago. Net income was INR 15.06 million compared to net loss of INR 0.795 million a year ago. Basic earnings per share from continuing operations was INR 0.038 compared to basic loss per share from continuing operations of INR 0.002 a year ago. Diluted earnings per share from continuing operations was INR 0.038 compared to diluted loss per share from continuing operations of INR 0.002 a year ago.